@misc{indiciaefab7e5634763,
  title = {FDA-Approved Drug Screening in Patient-Derived Organoids Demonstrates Potential of Drug Repurposing for Rare Cystic Fibrosis Genotypes},
  author = {de Poel, E. and Spelier, S. and Hagemeijer, M. C. and van Mourik, P. and Suen, S. W. F. and Vonk, A. M. and Brunsveld, J. E. and Ithakisiou, G. N. and Kruisselbrink, E. and Oppelaar, H. and Berkers, G. and de Winter-de Groot, K. M. and Heida-Michel, S. and Jans, S. R. and van Panhuis, H. and Bakker, M. and van der Meer, R. and Roukema, J. and Dompeling, E. and Weersink, E. J. M. and Koppelman, G. H. and Blaazer, A. R. and van Muijlwijk - Koezen, J. E. and van der Ent, C. K. and Beekman, J. M.},
  year = {2022},
  doi = {10.1101/2022.09.02.506304},
  url = {https://www.biorxiv.org/content/10.1101/2022.09.02.506304v1},
  note = {Source identifier: 10.1101/2022.09.02.506304}
}